12
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Liposomal Delivery of Oligodeoxynucleotides

, , , &
Pages 93-97 | Received 01 May 1995, Published online: 01 Jul 2009

References

  • Wagner R. W. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994; 372: 333–335
  • Stein C. A. Antisense oligodeoxynucleotides as therapeutic agents. Contemporary Oncology 1994; 4: 31–39
  • Stein C. A., Narayanan R. Antisense oligodeoxynucleotides. Curr. Opin. in Oncol 1994; 6: 587–594
  • Tari A. M., Lopez-Berestein G. Antisense oligonucleotides and carriers for gene therapy. The Cancer Bulletin 1993; 45: 164–170
  • Stein C. A., Cheng Y.-C. Antisense oligonucleotides as therapeutic agents–Is the bullet really magical?. Science 1993; 261: 1004–1012
  • Akhtar A., Shoji Y., Juliano R. L. Pharmaceutical aspects of the biological stability and membrane transport characteristics of antisense oligonucleotides. Gene Regulation: Biology of Antisense RNA and DNA, R. P. Erickson, J. G. Izant. Raven Press, Ltd, New York 1992; 133–145
  • Stein C. A., Cohen J. S. Oligodeoxynucleotides as inhibitors of gene expression: a review. Cancer Res 1988; 48: 2659–2668
  • Eder P. S., DeVine R. J., Dagle J. M., Walder J. A. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma. Antisense Res. Dev 1991; 1: 141–151
  • Miller P. S., McParland K. B., Jayaraman K. Biochemical and biological effects of nonionic nucleic acid methylphosphonates. Biochemistry 1981; 20: 1874–1880
  • Wickstrom E. Antisense DNA therapeutics: Neutral analogs and their stereochemistry. Gene Regulation: Biology of Antisense RNA and DNA, R. P. Erickson, J. G. Izant. Raven Press, Ltd, New York 1992; 119–132
  • Marti G., Egan W., Noguchi P., Zon G., Matsukura M., Broder S. Oligodeoxynucleotide phosphorothioate fluxes and localization in hematopoietic cells. Antisense Res. Dev 1992; 2: 27–39
  • Tonkinson J. L., Stein C. A. Patterns of intracellular compartmentalization trafficking and acidification of 5'-fluorescein-labeled phosphodiester and phosphorothioate oligonucleotides in HL60 cells. Nucleic Acids Res 1994; 22: 4268–4275
  • Geselowitz D. A., Neckers L. M. Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker. Antisense Res. Dev 1992; 2: 17–25
  • Thierry A. R., Dritschilo A. Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Nucleic Acids Res 1992; 20: 5691–5698
  • Martiat P., Lewalle P., Taj A. S., Larondelle Y., Vaerman J. L., Wildmann C., Goldman J. M., Michaux J. L. Retrovirally transduced antisense sequences stably suppress p210Bcr-Abl expression and inhibit the proliferation of BCR/ABL-containing cell lines. Blood 1993; 81: 502–509
  • Huang X. M., Wei S. G., Wang L. F. Reversal of malignant phenotype of human hepatoma cells by antisense c-ets-2, c-myc and N-ras. Chung Hua Chung Liu Tsa Chih 1994; 16: 243–246
  • Ghimikar R. S., Yu A. C., Eng L. F. Astrogliosis in culture: III. Effect of recombinant retrovirus expressing antisense glial fibrillary acidic protein RNA. J. Neurosci. Res 1994; 38: 376–385
  • Tung F. Y., Daniel M. D. Targeted inhibition of immunodeficiency virus replication in lymphocytes through retroviral mediated gene transfer. Arch. Virol 1993; 133: 407–421
  • Kaiser S. M., Sebag M., Rhim J. S., Kremer R., Goltzman D. Antisense-mediated inhibition of parathyroid hormone-related peptide production in a keratinocyte cell line impedes differentiation. Mol. Endocrinol 1994; 8: 139–147
  • Zhang Y., Mukhopadhyay T., Donehower L. A., Georges R. N., Roth J. A. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Hum. Gene Ther 1993; 4: 451–460
  • Bennett C. F., Chiang M. Y., Chan H., Shoemaker J. E. E., Mirabelli C. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol 1992; 41: 1023–1033
  • Busch R. K., Perlaky L., Valdez B. C., Henning D., Busch H. Apoptosis in human tumor cells following treatment with p120 antisense oligodeoxynucleotide ISIS 3466. Cancer Lett 1994; 86: 151–157
  • Lappalainen K., Urtti A., Soderling E., Jaaskelainen I., Syrjanen K., Syrjanen S. Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells. Biochim. Biophys. Acta 1994; 1196: 201–208
  • Ropert C., Malvy C., Couvreur P. Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action. Pharm. Res 1993; 10: 1427–1433
  • Thierry A. R., Rahman A., Dritschilo A. Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides. Biochem. Biophys. Res. Commun 1993; 190: 952–960
  • Tari A. M., Tucker S. D., Deisseroth A., Lopez-Berestein G. Liposomal delivery methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia. Blood 1994; 84: 601–407
  • Juliano R. L., Akhtar S. Liposomes as a drug delivery system for antisense oligonucleotides. Antisense Res. Develop 1992; 2: 165–176
  • Thierry A. R., Rahman A., Dritschilo A. Liposomal delivery as a new approach to transport antisense oligonucleotides. Gene Regulation: Biology of Antisense RNA and DNA, R. P. Erickson, J. G. Izant. Raven Press, Ltd, New York 1992; 147–161

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.